INS and diabetes mellitus: The patients in this study were using a smart insulin pen (NovoPen 6) in conjunction with CGM, but still experienced missed basal insulin doses; therefore, the addition of a smart insulin pen alone may not be sufficient to ensure 100% adherence to diabetes therapies among patients with T1D.